IDH2 and myelodysplastic syndrome: These observations indicate an increase of the frequency of IDH2 mutations in the progression from low-risk to high-risk MDS and then to AML; the frequency of IDH1 mutations clearly increases in the progression from high-risk MDS to AML [21].